STOCK TITAN

Myomo (MYO) CFO granted 8,727 RSUs in salary exchange plan on 10% pay

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Myomo, Inc. reported a new equity award to its Chief Financial Officer, David A. Henry. On January 12, 2026, he acquired 8,727 shares of common stock at a stated price of $0 per share, increasing his total beneficial ownership to 436,627 shares held directly.

According to the footnote, the award represents Restricted Stock Units granted under a Board-approved program that allows employees to forego 10% of their salary in exchange for RSUs with a grant date fair value of 115% of the salary exchanged. This particular grant covers three months of salary and the RSUs vest in full on April 12, 2026.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HENRY DAVID A

(Last) (First) (Middle)
C/O MYOMO, INC.
45 BLUE SKY DR., SUITE 101

(Street)
BURLINGTON MA 01803

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MYOMO, INC. [ MYO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
01/12/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/12/2026 A 8,727(1) A $0 436,627 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents a grant of Restricted Stock Units ("RSU's") under a program approved by the Company's Board of Directors allowing exployees to forego 10% of their salary in exchange for a grant of RSUs with a grant date fair value of 115% of such salary exchanged. This grant covers the exchange of three months of salary. RSU's under this grant vest in their entirety on April 12, 2026.
/s/ David A. Henry 01/14/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Myomo (MYO) CFO’s latest Form 4 filing report?

It shows that Chief Financial Officer David A. Henry acquired 8,727 shares of Myomo common stock on January 12, 2026, through a Restricted Stock Unit grant.

How many Myomo (MYO) shares does the CFO own after this transaction?

After the reported RSU grant, the CFO beneficially owns 436,627 shares of Myomo common stock, held directly.

What is the structure of the RSU program described in the Myomo (MYO) filing?

The RSUs are granted under a program approved by the Board that allows employees to forego 10% of their salary in exchange for RSUs with a grant date fair value equal to 115% of the salary exchanged.

What period of salary does this Myomo (MYO) RSU grant cover?

The filing states that this RSU grant covers the exchange of three months of salary for the participating employee.

When do the newly granted Myomo (MYO) RSUs to the CFO vest?

The RSUs reported in the filing vest in their entirety on April 12, 2026.

Did the Myomo (MYO) CFO pay cash for the 8,727 shares reported?

No cash purchase price is shown; the filing reports 8,727 shares acquired at a price of $0 per share in connection with the salary-for-RSU exchange program.
Myomo

NYSE:MYO

MYO Rankings

MYO Latest News

MYO Latest SEC Filings

MYO Stock Data

36.48M
35.62M
6.99%
66.68%
3.84%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
BOSTON